Ratings by Freedom Capital (Ilya Zubkov)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/30/2026 | Perfect Corp. | PERF | Downgrade | Hold (Buy) |
1.66 (1.66) |
0% | Details | |
| 3/23/2026 | Black Diamond Therapeutics | BDTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2026 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Butterfly Network | BFLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Legacy Reserves | LGCY | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Alnylam Pharmaceuticals | ALNY | Upgrade | Buy (Hold) |
314.40 (292.58) |
-6.94% | Details | |
| 2/12/2026 | Electromed | ELMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Eli Lilly | LLY | Upgrade | Buy (Hold) |
1044.67 (1078.78) |
3.27% | Details | |
| 2/9/2026 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Abbott Labs | ABT | Upgrade | Buy (Hold) |
106.05 (86.99) |
-17.97% | Details | |
| 1/27/2026 | Johnson & Johnson | JNJ | Maintain | Hold (N/A) |
|
Details | ||
| 11/24/2025 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Candel Therapeutics Inc. | CADL | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Owlet Inc. | OWLT | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Eli Lilly | LLY | Downgrade | Hold (Buy) |
924.37 (1044.67) |
13.01% | Details |
